Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Wittig, B
701  Ergebnisse:
Personensuche X
?
1

Induction of tumor-specific immune responses by the TLR9 ag..:

Volz, B. ; Kapp, K. ; Oswald, D...
European Journal of Cancer.  110 (2019)  - p. S13 , 2019
Link: https://doi.org/10.1016/..
 
?
2

A new family of potent TLR9 agonists, EnanDIM, which inhibi..:

Volz, B. ; Kapp, K. ; Oswald, D...
European Journal of Cancer.  92 (2018)  - p. S5-S6 , 2018
Link: https://doi.org/10.1016/..
 
?
3

Immunotherapeutic maintenance treatment with toll-like rece..:

Thomas, M. ; Ponce-Aix, S. ; Navarro, A....
Annals of Oncology.  29 (2018)  10 - p. 2076-2084 , 2018
Link: https://doi.org/10.1093/..
 
?
4

The TLR9 agonist MGN1703 triggers a potent type I interfero..:

Krarup, A R ; Abdel-Mohsen, M ; Schleimann, M H...
Mucosal Immunology.  11 (2018)  2 - p. 449-461 , 2018
Link: https://doi.org/10.1038/..
 
?
5

Experimental simulation of dissimilar weld metal of high ma..:

Wittig, B . ; Zinke, M. ; Jüttner, S..
Welding in the World.  61 (2017)  2 - p. 249-256 , 2017
Link: https://doi.org/10.1007/..
 
?
6

Immunological and first anti-tumor data of the TLR9 agonist..:

Volz, B. ; Kapp, K. ; Oswald, D...
European Journal of Cancer.  72 (2017)  - p. S149-S150 , 2017
Link: https://doi.org/10.1016/..
 
?
7

2089 Response to chemotherapy allows to identify mCRC patie..:

Scheithauer, W. ; Riera-Knorrenschild, J. ; Kopp, H.G....
European Journal of Cancer.  51 (2015)  - p. S357-S358 , 2015
Link: https://doi.org/10.1016/..
 
?
8

Immune response of healthy horses to DNA constructs formula..:

Schnabel, Christiane L. ; Steinig, P. ; Koy, M....
BMC Veterinary Research.  11 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
9

Influences of age and sex on leukocytes of healthy horses a..:

Schnabel, C.L. ; Steinig, P. ; Schuberth, H.-J....
Veterinary Immunology and Immunopathology.  165 (2015)  1-2 - p. 64-74 , 2015
Link: https://doi.org/10.1016/..
 
?
10

Change of Burden of Disease in German Rheumatoid Arthritis ..:

Wolff, M. ; Kleine, H. ; Wittig, B..
Value in Health.  16 (2013)  7 - p. A568 , 2013
Link: https://doi.org/10.1016/..
 
?
11

6149 POSTER Preliminary Results of a Phase 2-3 Clinical Stu..:

Schmidt, M. ; Schmoll, H.J. ; Ghiringhelli, F....
European Journal of Cancer.  47 (2011)  - p. S437 , 2011
Link: https://doi.org/10.1016/..
 
?
12

47 Immunotherapy with the toll-like receptor 9 agonist MGN1..:

Weihrauch, M.R. ; Richly, H. ; von Bergwelt-Baildon, M.S....
European Journal of Cancer Supplements.  8 (2010)  7 - p. 24 , 2010
Link: https://doi.org/10.1016/..
 
?
13

46 Immunotherapy with the toll-like receptor 9 agonist MGN1..:

Weihrauch, M.R. ; von Bergwelt-Baildon, M.S. ; Hacker, U....
European Journal of Cancer Supplements.  8 (2010)  7 - p. 23-24 , 2010
Link: https://doi.org/10.1016/..
 
?
14

44LBA Results of a phase I clinical trial of MGN1703, a nov..:

Weihrauch, M. ; Schmidt, M. ; Tschaika, M....
European Journal of Cancer Supplements.  7 (2009)  3 - p. 19-20 , 2009
Link: https://doi.org/10.1016/..
 
?
15

Chronisch entzündliche Darmerkrankungen: Pathophysiologie u..:

Herrlinger, K. ; Wittig, B. ; Stange, E.F.
Der Internist.  50 (2009)  10 - p. 1229-1248 , 2009
Link: https://doi.org/10.1007/..
 
1-15